Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells-Reference-Cited by-同舟云学术

Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

Published:2010-04 Issue:7 Volume:9 Page:1399-1410
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Cusimano Antonella,Azzolina Antonina,Iovanna Juan L.,Bachvarov Dimcho,McCubrey James A.,D’Alessandro Natale,Montalto Giuseppe,Cervello Melchiorre

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.9.7.11254

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential impacts of nonsteroidal anti‐inflammatory drugs on lifespan and healthspan in aged Caenorhabditis elegans;Journal of Applied Toxicology;2024-06-05

2. Molecular mechanism of anti-inflammatory effects of the proteasome inhibitor MG-132 on Con A-induced acute liver injury in mice;Research in Veterinary Science;2023-03

3. The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway;Head & Face Medicine;2022-05-06

4. Cleavage of HSP90β induced by histone deacetylase inhibitor and proteasome inhibitor modulates cell growth and apoptosis;Cell Stress and Chaperones;2020-09-01

5. The cytotoxic concentration of rosmarinic acid increases MG132-induced cytotoxicity, proteasome inhibition, autophagy, cellular stresses, and apoptosis in HepG2 cells;Human & Experimental Toxicology;2019-12-26